Groggel G C, Hovingh P, Border W A, Linker A
Am J Pathol. 1987 Sep;128(3):521-7.
Changes in glomerular anionic sites in puromycin aminonucleoside nephrosis (PAN) in the rat are controversial. The authors examined glomerular anionic sites in PAN by in vivo staining with polyethyleneimine (PEI). They also quantitated and characterized glomerular heparan sulfate (HS), which is known to be a major glomerular polyanion in PAN, using in vivo incorporation of 35S-sulfate. PAN rats had a mean protein excretion of 96 +/- 23 mg per 24 hours. Staining of anionic sites with PEI showed 15.3 +/- 2.8 sites per 1000-nm length of glomerular basement membrane in controls, 13.7 +/- 1.9 sites in PAN rats (P greater than 0.05), and 50% of rats with early PAN had absent staining. Total 35S-sulfate incorporation was similar in both the controls and established PAN rats (2900 +/- 150 dpm/mg dry wt of glomeruli versus 3005 +/- 260, P greater than 0.05) but decreased in early PAN rats (2025 +/- 148). The percentage of 35S-sulfate incorporated into chondroitin sulfate was similar in all three groups of animals. HS uronic acid was also similar (1.8 +/- 0.2 g/mg dry wt of glomeruli versus 1.7 +/- 0.3, P greater than 0.05) but decreased in early PAN (1.1 +/- 0.2). The distribution of 35S-sulfate activity within the HS subfractions was examined by ion-exchange chromatography and showed a shift in percent present from 1.0 M to 1.25 M fraction in established and early PAN animals (control 1.0 M 37% +/- 3.2% versus PAN 19% +/- 3.4%, P less than 0.01, and 1.25 M 36% +/- 2.9% versus 53% +/- 2.9%, P less than 0.01). These results demonstrate that glomerular heparan sulfate is unchanged in established PAN but decreased in early PAN. SO4 incorporation is unchanged in established PAN and diminished in early PAN. Thus, early in PAN HS synthesis is impaired, but in established PAN the HS is normal, and changes in glomerular HS cannot explain the increased permeability.
大鼠嘌呤霉素氨基核苷肾病(PAN)中肾小球阴离子位点的变化存在争议。作者通过用聚乙烯亚胺(PEI)进行体内染色来检测PAN中的肾小球阴离子位点。他们还使用35S-硫酸盐的体内掺入来定量和表征肾小球硫酸乙酰肝素(HS),已知其是PAN中主要的肾小球聚阴离子。PAN大鼠每24小时的平均蛋白排泄量为96±23mg。用PEI对阴离子位点进行染色显示,对照组每1000nm肾小球基底膜长度有15.3±2.8个位点,PAN大鼠中有13.7±1.个位点(P>0.05),并且50%的早期PAN大鼠染色缺失。对照组和已确诊的PAN大鼠中35S-硫酸盐的总掺入量相似(肾小球干重每毫克2900±150dpm对3005±260,P>0.05),但早期PAN大鼠中减少(2025±148)。三组动物中掺入硫酸软骨素的35S-硫酸盐百分比相似。HS糖醛酸也相似(肾小球干重每毫克1.8±0.2μg对1.7±0.3,P>0.05),但早期PAN中减少(1.1±0.2)。通过离子交换色谱法检查了HS亚组分中35S-硫酸盐活性的分布,结果显示在已确诊和早期PAN动物中,存在百分比从1.0M部分向1.25M部分转移(对照组1.0M为37%±3.2%对PAN为19%±3.4%,P<0.01,1.25M为36%±2.9%对53%±2.9%,P<0.01)。这些结果表明,在已确诊的PAN中肾小球硫酸乙酰肝素未发生变化,但在早期PAN中减少。在已确诊的PAN中SO4掺入未发生变化,但在早期PAN中减少。因此,在PAN早期HS合成受损,但在已确诊的PAN中HS正常,并且肾小球HS的变化不能解释通透性增加的原因。